ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

GW501516

GW 501516

HCID 9803963
反応を作成
印刷

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
317318-70-0
標準SMILES
Cc1cc(SCc2sc(-c3ccc(C(F)(F)F)cc3)nc2C)ccc1OCC(=O)O
InChIKey
YDBLKRPLXZNVNB-UHFFFAOYSA-N
分子式
C21H18F3NO3S2
平均分子量
453.5 g/mol
単同位体質量
453.06802027

概要

GW 501516 is an aromatic ether that is phenoxyacetic acid in which the phenyl group is substituted at position 2 by a methyl group and at position 4 by a (1,3-thiazol-5-ylmethyl)sulfanediyl group, and in which the 1,3-thiazolyl group is substituted at positions 2 and 4 by p-trifluoromethylphenyl and methyl groups, respectively. It has a role as a carcinogenic agent and a PPARbeta/delta agonist. It is a monocarboxylic acid, an aromatic ether, an aryl sulfide, an organofluorine compound and a member of 1,3-thiazoles.

名称と識別子

優先名称
GW 501516
IUPAC
2-[2-methyl-4-[[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]methylsulfanyl]phenoxy]acetic acid
現地名
GW501516
英語名
GW-501516
分子式
C21H18F3NO3S2
分子量
453.5

名称と別名

317318-70-0EndurobolGW 501516GW501516GW-501516GSK-516GW1516GW-15167I2HA1NU222-[2-methyl-4-[[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]methylsulfanyl]phenoxy]acetic acid{2-methyl-4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]phenoxy}acetic acidDTXSID3041037
名称をさらに表示
2-[2-Methyl-4-[[[4-methyl-2-[4-(trifluoromethyl)phenyl]-5-thiazolyl]methyl]thio]phenoxy]acetic AcidCS-788CARDAROLGW-501615CardrarineGW501516 20mg
CHEBI:73726(2-methyl-4-(((4-methyl-2-(4-(trifluoromethyl)phenyl)-1,3-thiazol-5-yl)methyl)sulfanyl)phenoxy)acetic acid2-(2-methyl-4-((4-methyl-2-(4-(trifluoromethyl)phenyl)-1,3-thiazol-5-yl)methylsulfanyl)phenoxy)acetic acidRefChem:574663DTXCID1021037CardarineUNII-7I2HA1NU22GW 1516

データベース識別子

CAS
317318-70-0

物性

構造計算による物性補完中

XLogP
5.9
極性表面積
113 Ų
水素結合供与体数
1
水素結合受容体数
9
回転可能結合数
7
重原子数
30
形式電荷
0
複雑度
572

実験および物理化学的性質

DrugsPharmaceuticals -> Listed in ZINC15

物理化学的性質

融点
134 · 134-136°C
沸点
584.5 · 584.5±60.0 °C(Predicted)
比重(密度)
1.42 · 1.42±0.1 g/cm3(Predicted)
貯蔵温度
-20 °C · -20°C
溶解性
20 mg/mL、透明 · DMSO:可溶20mg/mL、透明
外見
粉
酸解離定数(Pka)
3.17 · 3.17±0.10(Predicted)
色
白からベージュ
BRN
18515150 · 18515150
安定性
光に敏感
InChI
InChI=1S/C21H18F3NO3S2/c1-12-9-16(7-8-17(12)28-10-19(26)27)29-11-18-13(2)25-20(30-18)14-3-5-15(6-4-14)21(22,23)24/h3-9H,10-11H2,1-2H3,(H,26,27)
InChIKey
YDBLKRPLXZNVNB-UHFFFAOYSA-N
SMILES
C(O)(=O)COC1=CC=C(SCC2SC(C3=CC=C(C(F)(F)F)C=C3)=NC=2C)C=C1C
CAS データベース
317318 · 317318-70-0

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

安全データ

wgk
3
rtecs
AI9105500
ストレージクラス
11 - Combustible Solids

化学と産業

薬理情報

Mechanism of Action · 1 件

This drug regulates fatty acid oxidation in several tissues, such as skeletal muscle and adipose tissue. Overexpression of PPARdelta using a transgenic murine model promotes an increase of muscle oxidative capability. It also plays a major role in the metabolic adaptations to western diet characterized by an excessive amount of saturated fat.

応用分野 · 4 件

説明GW501516, also known as GW-1516 or cardarine and endurobol, is a peroxisome proliferator-activated receptor delta (PPAR-δ) agonist. Activation of the receptor will increase fat-burning capacity and muscle production, as it changes the body's fuel preference from glucose to lipids.

来歴GW501516, also known as Cardarine, was originally discovered in the early 1990s during a research collaboration between two large pharmaceutical companies. The initial proposed use was for the treatment of hyperlipidemia (elevated fats in the blood), though later studies looked at its effectiveness for treating obesity, diabetes, and cardiovascular disease.

使用An experimental drug meant to control lipids and increase the level of HDL, or good cholesterol, in the bloodstream. A cell-permeable, thiazolyl compound that acts as a potent, high affinity, PPARd agonist. Exhibits selectivity for PPARd compared t

一般的な説明GW501516 is the most selective and potent PPARβ (EC50=1.1nM) agonist that has been demonstrated to be 1,000-fold more selective in comparison to existing subtypes. It can regulate expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells and has been shown to block insulin resistance and fatty acid-induced nuclear factor-κB (NF-κB) activation.

補足説明 · 1 件

定義ChEBI: An aromatic ether that is phenoxyacetic acid in which the phenyl group is substituted at position 2 by a methyl group and at position 4 by a (1,3-thiazol-5-ylmethyl)sulfanediyl group, and in which the 1,3-thiazolyl group is substituted at positions 2 and 4 by p-trifluoromethylphenyl and methyl groups, respectively.

関連反応

5 件
反応記録を作成
HRID 207424 の反応式
HRID 207424生成物として
HRID 852352 の反応式
HRID 852352反応物として
HRID 1014070 の反応式
HRID 1014070反応物として
HRID 1014073 の反応式
HRID 1014073生成物として
HRID 1242504 の反応式
HRID 1242504反応物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
PubChem CID
9803963
DTXSID
DTXSID3041037
ChEMBL
CHEMBL38943
ChEBI
CHEBI:73726
UNII
7I2HA1NU22
Nikkaji
J1.561.880I

化学的性質

化学的特性White Solid